5,7,3',4'-Tetrahydroxyflavone-3-yl 2-O-(3-methoxy-4-hydroxy-trans-cinnamoyl)-6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside

Details

Top
Internal ID 4fd4a554-f750-4377-81d0-9c3ad07354e0
Taxonomy Phenylpropanoids and polyketides > Flavonoids > Flavonoid glycosides > Flavonoid O-glycosides > Flavonoid-3-O-glycosides
IUPAC Name [(2S,3R,4S,5S,6R)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy-4,5-dihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-3-yl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
SMILES (Canonical) CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)OC(=O)C=CC6=CC(=C(C=C6)O)OC)O)O)O)O)O
SMILES (Isomeric) C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)OC(=O)/C=C/C6=CC(=C(C=C6)O)OC)O)O)O)O)O
InChI InChI=1S/C37H38O19/c1-14-27(44)30(47)32(49)36(52-14)51-13-24-28(45)31(48)35(55-25(43)8-4-15-3-6-19(40)22(9-15)50-2)37(54-24)56-34-29(46)26-21(42)11-17(38)12-23(26)53-33(34)16-5-7-18(39)20(41)10-16/h3-12,14,24,27-28,30-32,35-42,44-45,47-49H,13H2,1-2H3/b8-4+/t14-,24+,27-,28+,30+,31-,32+,35+,36+,37-/m0/s1
InChI Key PFLDHZMNADJRRZ-GFAWZACZSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C37H38O19
Molecular Weight 786.70 g/mol
Exact Mass 786.20072898 g/mol
Topological Polar Surface Area (TPSA) 301.00 Ų
XlogP 1.00
Atomic LogP (AlogP) 0.29
H-Bond Acceptor 19
H-Bond Donor 10
Rotatable Bonds 10

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of 5,7,3',4'-Tetrahydroxyflavone-3-yl 2-O-(3-methoxy-4-hydroxy-trans-cinnamoyl)-6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.5497 54.97%
Caco-2 - 0.9023 90.23%
Blood Brain Barrier - 0.8500 85.00%
Human oral bioavailability - 0.7714 77.14%
Subcellular localzation Mitochondria 0.5992 59.92%
OATP2B1 inhibitior - 0.5652 56.52%
OATP1B1 inhibitior + 0.8692 86.92%
OATP1B3 inhibitior + 0.9722 97.22%
MATE1 inhibitior - 0.9000 90.00%
OCT2 inhibitior - 0.8250 82.50%
BSEP inhibitior + 0.7405 74.05%
P-glycoprotein inhibitior + 0.6380 63.80%
P-glycoprotein substrate + 0.6865 68.65%
CYP3A4 substrate + 0.6967 69.67%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8699 86.99%
CYP3A4 inhibition - 0.8455 84.55%
CYP2C9 inhibition - 0.8273 82.73%
CYP2C19 inhibition - 0.8803 88.03%
CYP2D6 inhibition - 0.9211 92.11%
CYP1A2 inhibition - 0.9283 92.83%
CYP2C8 inhibition + 0.9096 90.96%
CYP inhibitory promiscuity - 0.7127 71.27%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 1.0000 100.00%
Carcinogenicity (trinary) Non-required 0.6664 66.64%
Eye corrosion - 0.9899 98.99%
Eye irritation - 0.9089 90.89%
Skin irritation - 0.8297 82.97%
Skin corrosion - 0.9490 94.90%
Ames mutagenesis - 0.6365 63.65%
Human Ether-a-go-go-Related Gene inhibition + 0.8112 81.12%
Micronuclear + 0.7392 73.92%
Hepatotoxicity - 0.5250 52.50%
skin sensitisation - 0.9104 91.04%
Respiratory toxicity + 0.5778 57.78%
Reproductive toxicity + 0.8333 83.33%
Mitochondrial toxicity + 0.5375 53.75%
Nephrotoxicity - 0.9884 98.84%
Acute Oral Toxicity (c) III 0.5896 58.96%
Estrogen receptor binding + 0.8218 82.18%
Androgen receptor binding + 0.6137 61.37%
Thyroid receptor binding + 0.5536 55.36%
Glucocorticoid receptor binding + 0.6770 67.70%
Aromatase binding + 0.5567 55.67%
PPAR gamma + 0.7451 74.51%
Honey bee toxicity - 0.6920 69.20%
Biodegradation - 0.8000 80.00%
Crustacea aquatic toxicity + 0.5100 51.00%
Fish aquatic toxicity + 0.9512 95.12%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.85% 91.11%
CHEMBL1806 P11388 DNA topoisomerase II alpha 99.13% 89.00%
CHEMBL1293249 Q13887 Kruppel-like factor 5 98.95% 86.33%
CHEMBL1951 P21397 Monoamine oxidase A 98.89% 91.49%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 96.32% 96.09%
CHEMBL3194 P02766 Transthyretin 96.24% 90.71%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 95.72% 96.00%
CHEMBL3060 Q9Y345 Glycine transporter 2 94.16% 99.17%
CHEMBL2085 P14174 Macrophage migration inhibitory factor 94.00% 80.78%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 93.26% 95.56%
CHEMBL2581 P07339 Cathepsin D 92.91% 98.95%
CHEMBL2345 P51812 Ribosomal protein S6 kinase alpha 3 90.25% 95.64%
CHEMBL3401 O75469 Pregnane X receptor 89.97% 94.73%
CHEMBL3091268 Q92753 Nuclear receptor ROR-beta 87.48% 95.50%
CHEMBL4208 P20618 Proteasome component C5 87.11% 90.00%
CHEMBL3714130 P46095 G-protein coupled receptor 6 87.08% 97.36%
CHEMBL1860 P10827 Thyroid hormone receptor alpha 86.28% 99.15%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 85.49% 94.00%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 82.37% 85.14%
CHEMBL3137262 O60341 LSD1/CoREST complex 82.13% 97.09%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 81.51% 94.45%
CHEMBL5339 Q5NUL3 G-protein coupled receptor 120 80.75% 95.78%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 80.67% 95.89%

Cross-Links

Top
PubChem 101781232
NPASS NPC1712